Under the terms of the Agreement, the Selling Shareholder will transfer 51% of NEURALAND's issued and outstanding shares to the Company in exchange for 1,162,025,300 newly issued Class A ordinary shares of the Company (the "Company Exchange Shares") valued US$0.0079 per share, corresponding to US$0.79 per American Depositary Share ("ADS") (based on the current ADS ratio of one hundred (100) Class A ordinary shares per ADS), representing a total consideration of approximately US$9.18 million. The per share price for the Company Exchange Shares was determined based on the average of the closing prices of the Company's American Depositary Shares on the NYSE over the thirty (30) trading days immediately preceding the date of the Agreement. The number of Company Exchange Shares was calculated by dividing the total consideration by the per share price, with any fractional shares rounded down.